SAINT LAURENT, Quebec, April 05, 2024 IntelGenx Corp. today announced that its co-developer, Chemo Research SL, through its agent and affiliate, Xiromed LLC , has received a Complete Response.
SAINT LAURENT, Quebec, Sept. 19, 2023 IntelGenx Corp. today provided a regulatory update on Buprenorphine Buccal Film, for which an abbreviated new drug application has been filed with the.
IntelGenx Announces Receipt of Complete Response Letter from the FDA for Xiromed-Partnered Buprenorphine Buccal Film streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.